EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in male neutered cats

Bruno H Pypendop, Yu Hong Law, Juhana Honkavaara, Linda S Barter

Veterinary Anaesthesia and Analgesia · 2025

DOI: 10.1016/j.vaa.2025.01.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Anaesthesia and Analgesia, 2025. Verfasst von Bruno H Pypendop und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA. Electronic address: bhpype…. Hauptthemen laut MEDLINE: Dexmedetomidine, Ketamine, Hypnotics and Sedatives, Quinolizines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: School of Veterinary Medicine, University of California, Davis, Center for Companion Animal Health, University of California, Davis, EveryCat Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To characterize the pharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in cats. STUDY DESIGN: Partially randomized, crossover, experimental study. ANIMALS: A group of six healthy male neutered cats, aged 1-2 years, weighing 5.4 ± 0.3 kg. METHODS: Each cat was administered six treatments: dexmedetomidine (25 μg kg-1; D) + vatinoxan (600 μg kg-1; V) + ketamine (2.5 mg kg-1; K2.5) intramuscularly (IM) (DVK2.5IM); D + V + ketamine (5 mg kg-1; K5) IM (DVK5IM); D + V + ketamine (10 mg kg-1; K10) IM (DVK10IM); D + K5 IM (DK5IM); D + V + K5 subcutaneously (SC) (DVK5SC); or D + V + K5 intravenously (IV) (DVK5IV). Venous blood samples were collected before treatment injection, and at various times up to 6 hours thereafter. Plasma dexmedetomidine, vatinoxan and ketamine concentrations were measured using liquid chromatography/tandem mass spectrometry. Compartment models were fitted to the time-plasma dexmedetomidine, vatinoxan and ketamine data using nonlinear mixed effect modeling, including covariates for the effects of vatinoxan and the dose of ketamine where appropriate. RESULTS: Two-compartment models best fitted the time-plasma dexmedetomidine, vatinoxan and ketamine concentrations. The models predicted that vatinoxan increases the clearance of dexmedetomidine and decreases the bioavailability of IM ketamine and that increasing doses of ketamine increase the volume of the central compartment for dexmedetomidine and the bioavailability of IM ketamine. The volume of distribution at steady state (mL kg-1) and metabolic clearance (mL minute-1 kg-1) were 1012-2429 and 12.5-15.4 for dexmedetomidine, 666 and 3.7 for vatinoxan and 2260 and 23.8 for ketamine, respectively. Bioavailability (%) for IM and SC dexmedetomidine, vatinoxan and ketamine was 83 and 95, 99 and 95 and 60-100 and 100, respectively. CONCLUSIONS AND CLINICAL RELEVANCE: The pharmacokinetics of dexmedetomidine and the bioavailability of ketamine were affected by vatinoxan and the dose of ketamine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineKetamineHypnotics and SedativesQuinolizinesAnimalsMaleCatsCross-Over StudiesAnesthetics, Dissociative

Stichwörter der Autor:innen

catsdexmedetomidineketaminepharmacokineticsvatinoxan

Substanzen

DexmedetomidineKetaminevatinoxanHypnotics and SedativesQuinolizinesAnesthetics, Dissociative

Autor:innen und Institutionen

  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA. Electronic address: bhpypendop@ucdavis.edu.
  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA.
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.

Förderung

  • School of Veterinary Medicine, University of California, Davis
  • Center for Companion Animal Health, University of California, Davis
  • EveryCat Health Foundation

Zitieren

APA

Pypendop, B. H., Law, Y. H., Honkavaara, J., & Barter, L. S. (2025). Pharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in male neutered cats. Veterinary Anaesthesia and Analgesia. https://doi.org/10.1016/j.vaa.2025.01.015

Vancouver

Pypendop BH, Law YH, Honkavaara J, Barter LS. Pharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in male neutered cats. Veterinary Anaesthesia and Analgesia. 2025. doi:10.1016/j.vaa.2025.01.015

BibTeX
@article{Pypendop2025,
  author = {Pypendop, Bruno H and Law, Yu Hong and Honkavaara, Juhana and Barter, Linda S},
  title = {Pharmacokinetics of combinations of dexmedetomidine, vatinoxan and ketamine in male neutered cats},
  journal = {Veterinary Anaesthesia and Analgesia},
  year = {2025},
  doi = {10.1016/j.vaa.2025.01.015}
}
Kostenlos starten →